Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
about
A non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre.Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric studyClinical safety of biosimilar recombinant human granulocyte colony-stimulating factors.Clinical experience with Zarzio® in Europe: what have we learned?Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis.Top-down MS for rapid methionine oxidation site assignment in filgrastim.
P2860
Q36348464-B8D22BC6-2978-4E68-B132-27C1257335ACQ36723952-E54F06E9-0581-48B9-BEF4-72169F78721EQ38082542-CD8F7675-2BE4-4349-8150-E35DD9F9FC5AQ38125609-D2122B4D-25F8-479E-A236-185D7FF3FC1DQ38225700-71FEBEA5-28CB-420E-BAEB-A9D652193777Q40141879-68F98C64-FCCF-4F5E-8CBF-29AB652B5CD8Q41547224-EFFF928B-9C62-4CC6-B869-F96FBAD9223CQ41976373-A7ECF1D1-7157-4D76-AA0D-A0FC2B8CC3E2
P2860
Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
@en
Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
@nl
type
label
Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
@en
Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
@nl
prefLabel
Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
@en
Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
@nl
P2093
P356
P1433
P1476
Biosimilar medicines in oncology: single-center experience with biosimilar G-CSF.
@en
P2093
Barbara Di Cocco
Enzo Veltri
Maria Colonna
Nello Salesi
P2860
P304
P356
10.2217/FON.12.32
P407
P577
2012-03-08T00:00:00Z